NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

脑震荡的全球市场:未来展望

Global Concussions Market Research Report Forecast to 2023

出版商 Market Research Future 商品编码 872608
出版日期 内容资讯 英文 118 Pages
订单完成后即时交付
价格
脑震荡的全球市场:未来展望 Global Concussions Market Research Report Forecast to 2023
出版日期: 2019年05月31日内容资讯: 英文 118 Pages
简介

本报告提供全球脑震荡诊断·治疗的相关市场相关分析,提供疾病概要和市场基本结构,主要的推动及阻碍市场要素,整体市场趋势预测 (过去4年·今后5年份),诊断/治疗各阶段·各终端用户·各地区的详细趋势,市场占有率结构,主要企业的简介·业绩·策略等调查。

第1章 摘要整理

第2章 分析概要

第3章 分析方法

第4章 市场动态

  • 概要
  • 推动市场要素
  • 阻碍市场要素
  • 市场机会

第5章 市场要素分析

  • 价值链分析
    • 研究开发 (R&D)
    • 制造
    • 流通·销售
    • 售后服务/监测
  • 波特的五力分析
  • 投资规划
  • 价格趋势分析

第6章 全球脑震荡市场:诊断·治疗各阶段

  • 概况
  • 诊断方法
  • 治疗方法

第7章 全球脑震荡市场:各终端用户

  • 概要
  • 医院·诊疗所
  • 诊断中心
  • 付款者

第8章 全球脑震荡市场:各地区

  • 概要
  • 南北美洲
    • 北美 (美国,加拿大)
    • 南美
  • 欧洲
    • 西欧 (德国,法国,英国,义大利,西班牙等)
    • 东欧
  • 亚太地区 (中国,日本,印度,澳洲,韩国等)
  • 中东·非洲

第9章 竞争环境

  • 竞争方案
  • 脑震荡治疗产业的代表性的企业
  • 脑震荡治疗产业的代表性的企业
  • 主要的结论

第10章 企业简介

  • Teva Pharmaceutical Industries Ltd
    • 企业概要
    • 主要的财务指标
    • 主要产品/服务
    • 近几年的主要趋势
    • SWOT分析
    • 主要策略
  • Integra LifeSciences Corporation
  • Medtronic Plc
  • Sun Pharmaceutical Industries Ltd
  • Lupin
  • Zydus Cadila
  • Pfizer, Inc.
  • Mylan N.V.
  • Novartis AG
  • Sanofi S. A.

第11章 结论

  • 主要的分析结果
目录

Global Concussions Market Information: by Diagnosis & Treatment (Diagnosis, Treatment), End User (Hospitals and Clinics, Diagnostic Centers, Payers, Others), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2023

Market analysis

Head wounds that are extreme enough to influence cerebrum capacities are named as traumatic brain injuries (TBI). A blackout or concussion is a type of mellow traumatic head wounds. Rising instances of concussion combined with the developing item improvement for the administration of concussion by a few organizations have prompted the development of the global concussions market as of late. Furthermore, the developing geriatric populace is likewise expected to fuel the development of the market. In any case, the absence of a prepared workforce in various creating and immature economies is probably going to hamper the market development over the estimated time frame. As indicated by a paper distributed by the National Center for Biotechnology Information (NCBI) in March 2015, roughly 42 million individuals all inclusive endure mild traumatic brain injury (MTBI) or concussion consistently. Consequently, the expanding rate of concussions is relied upon to give ideal foundations to the market to develop over the figure time frame. The Global Concussions Market is projected to register a growth rate of CAGR 3.22% to reach the value of USD 1,060.4 million until the year 2023.

Market segmentation

The global concussions market is segmented on the basis of its Diagnosis & Treatment, end-user, and regional demand. On the basis of its Diagnosis & Treatment, the global concussions market is bifurcated as Treatment and Diagnosis. Based on its end-user, the global concussions market is divided into Diagnostic Centers, Hospitals and Clinics, Payers, Others.

Regional analysis

Geographically, the global concussions market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Medtronic Plc, Integra LifeSciences Corporation, and Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, Mylan N.V., Pfizer, Inc., Zydus Cadila, Lupin, among others are some of the major players in the global concussions market.

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Overview
  • 4.2 Drivers
    • 4.2.1 Increasing Incidence of Mild Traumatic Brain Injuries
    • 4.2.2 Ongoing Product Development and Approval
    • 4.2.3 Growing Geriatric Population
  • 4.3 Restraints
    • 4.3.1 Stringent Regulatory Framework
    • 4.3.2 Shortage of Trained Professionals
  • 4.4 Opportunities
    • 4.4.1 Growing Awareness about Concussions

5 Market Factor Analysis

    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-Sales Services
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis

6 Global Concussions Market by Diagnosis & Treatment

  • 6.1 Overview
  • 6.2 Diagnosis
  • 6.3 Treatment

7 Global Concussions Market, by End User

  • 7.1 Overview
  • 7.2 Hospitals and Clinics
  • 7.3 Diagnostic Centers
  • 7.4 Payers

8 Global Concussions Market, by Region

  • 8.1 Overview
  • 8.2 Americas
    • 8.2.1 North America
      • 8.2.1.1 US
      • 8.2.1.2 Canada
    • 8.2.2 Latin America
  • 8.3 Europe
    • 8.3.1 Western Europe
      • 8.3.1.1 Germany
      • 8.3.1.2 France
      • 8.3.1.3 UK
      • 8.3.1.4 Italy
      • 8.3.1.5 Spain
      • 8.3.1.6 Rest of Western Europe
    • 8.3.2 Eastern Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 Middle East & Africa
    • 8.5.1 Middle East
    • 8.5.2 Africa

9 Competitive Landscape

  • 9.1 Competitive Scenario
  • 9.2 Prominent Players in the Concussion Therapeutics Industry
  • 9.3 Prominent Players in the Concussion Diagnostic Industry
  • 9.4 Key Developments

10 Company Profile

  • 10.1 Teva Pharmaceutical Industries Ltd
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products/Services Offered
    • 10.1.4 Key Developments
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Strategies
  • 10.2 Integra LifeSciences Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products Offering
    • 10.2.4 Key Developments
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Strategies
  • 10.3 Medtronic Plc
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Products Offering
    • 10.3.4 Key Developments
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Strategies
  • 10.4 Sun Pharmaceutical Industries Ltd
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products/Services Offered
    • 10.4.4 Key Developments
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Strategies
  • 10.5 Lupin
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products/Services Offered
    • 10.5.4 Key Developments
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Strategies
  • 10.6 Zydus Cadila
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products/Services Offered
    • 10.6.4 Key Developments
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Strategies
  • 10.7 Pfizer, Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products/Services Offered
    • 10.7.4 Key Developments
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Strategies
  • 10.8 Mylan N.V.
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Products/Services Offered
    • 10.8.4 Key Developments
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Strategies
  • 10.9 Novartis AG
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Products/Services Offered
    • 10.9.4 Key Developments
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Strategies
  • 10.1 Sanofi S. A.
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Products/Services Offered
    • 10.10.4 Key Developments
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Strategies

11 Appendix

  • 11.1 References
  • 11.2 Related Reports

List of Tables

  • TABLE 1 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 2 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSIS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 3 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL CONCUSSIONS MARKET FOR TREATMENT, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL CONCUSSIONS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL CONCUSSIONS MARKET FOR PAYERS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 AMERICAS: CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 12 AMERICAS: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 13 AMERICAS: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 14 AMERICAS: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 15 AMERICAS: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 16 NORTH AMERICA: CONCUSSIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 17 NORTH AMERICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 18 NORTH AMERICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 19 NORTH AMERICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 20 NORTH AMERICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 21 US: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 22 US: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 23 US: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 24 US: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 25 CANADA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 26 CANADA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 CANADA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 28 CANADA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 29 LATIN AMERICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 30 LATIN AMERICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 31 LATIN AMERICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 33 EUROPE: CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 34 EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 35 EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 36 EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 37 EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 38 WESTERN EUROPE: CONCUSSIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 39 WESTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 40 WESTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 41 WESTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 42 WESTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 43 GERMANY: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 44 GERMANY: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 GERMANY: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 46 GERMANY: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 47 FRANCE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 48 FRANCE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 49 FRANCE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 50 FRANCE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 51 UK: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 52 UK: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 UK: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 54 UK: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 55 ITALY: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 56 ITALY: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 ITALY: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 58 ITALY: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 59 SPAIN: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 60 SPAIN: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 SPAIN: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 62 SPAIN: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 63 REST OF WESTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 64 REST OF WESTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 REST OF WESTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 66 REST OF WESTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 67 EASTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 68 EASTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 69 EASTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 70 EASTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 71 ASIA-PACIFIC: CONCUSSIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 72 ASIA-PACIFIC: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 73 ASIA-PACIFIC: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 74 ASIA-PACIFIC: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 75 ASIA-PACIFIC: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 76 CHINA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 77 CHINA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 78 CHINA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 79 CHINA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 80 JAPAN: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 81 JAPAN: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 JAPAN: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 83 JAPAN: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 84 INDIA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 85 INDIA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 86 INDIA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 87 INDIA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 88 AUSTRALIA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 89 AUSTRALIA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 AUSTRALIA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 91 AUSTRALIA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 92 SOUTH KOREA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 93 SOUTH KOREA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 94 SOUTH KOREA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 95 SOUTH KOREA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 96 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 97 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 98 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 99 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 100 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 101 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 103 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 104 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 105 MIDDLE EAST: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 106 MIDDLE EAST: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 107 MIDDLE EAST: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 108 MIDDLE EAST: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 109 AFRICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2015-2023 (USD MILLION)
  • TABLE 110 AFRICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 AFRICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 112 AFRICA: CONCUSSIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 113 MAJOR PLAYERS IN THE CONCUSSION DIAGNOSTIC MARKET
  • TABLE 114 GLOBAL CONCUSSION MARKET: KEY DEVELOPMENT

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL CONCUSSIONS MARKET
  • FIGURE 3 GLOBAL CONCUSSIONS MARKET SHARE, BY DIAGNOSIS AND TREATMENT, 2017 (%)
  • FIGURE 4 GLOBAL CONCUSSIONS MARKET BY DIAGNOSIS AND TREATMENT, 2016-2023 (USD MILLION)
  • FIGURE 5 GLOBAL CONCUSSIONS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • FIGURE 6 GLOBAL CONCUSSIONS MARKET BY END USER, 2016-2023 (USD MILLION)
  • FIGURE 7 GLOBAL CONCUSSIONS MARKET: MARKET STRUCTURE
  • FIGURE 8 RESEARCH PROCESS OF MRFR
  • FIGURE 9 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 10 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CONCUSSIONS MARKET
  • FIGURE 11 VALUE CHAIN: GLOBAL CONCUSSIONS MARKET
  • FIGURE 12 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONCUSSIONS MARKET
  • FIGURE 13 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2017 (%)
  • FIGURE 14 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2017 AND 2023 (USD MILLION)
  • FIGURE 15 GLOBAL CONCUSSIONS MARKET, BY END USER, 2017 (%)
  • FIGURE 16 GLOBAL CONCUSSIONS MARKET, BY END USER, 2017 AND 2023 (USD MILLION)
  • FIGURE 17 GLOBAL CONCUSSIONS MARKET, BY REGION, 2017 (%)
  • FIGURE 18 GLOBAL CONCUSSIONS MARKET, BY REGION, 2017 AND 2023 (USD MILLION)
  • FIGURE 19 AMERICAS: CONCUSSIONS MARKET, BY REGION, 2017 AND 2023
  • FIGURE 20 NORTH AMERICA: CONCUSSIONS MARKET, BY COUNTRY, 2017 AND 2023
  • FIGURE 21 EUROPE: CONCUSSIONS MARKET, BY REGION, 2017 AND 2023
  • FIGURE 22 WESTERN EUROPE: CONCUSSIONS MARKET, BY COUNTRY, 2017 AND 2023
  • FIGURE 23 ASIA-PACIFIC: CONCUSSIONS MARKET, BY COUNTRY, 2017 AND 2023
  • FIGURE 24 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY REGION, 2017 AND 2023
  • FIGURE 25 MAJOR PLAYERS IN CONCUSSION THERAPEUTICS MARKET
  • FIGURE 26 GLOBAL CONCUSSION MARKET, COMPETITIVE LANDSCAPE (%)